IRIS Accounts Production v24.3.2.46 10743197 director 1.5.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107431972023-04-30107431972024-09-30107431972023-05-012024-09-30107431972022-04-30107431972022-05-012023-04-30107431972023-04-3010743197ns15:EnglandWales2023-05-012024-09-3010743197ns14:PoundSterling2023-05-012024-09-3010743197ns10:Director12023-05-012024-09-3010743197ns10:PrivateLimitedCompanyLtd2023-05-012024-09-3010743197ns10:SmallEntities2023-05-012024-09-3010743197ns10:AuditExemptWithAccountantsReport2023-05-012024-09-3010743197ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-09-3010743197ns10:SmallCompaniesRegimeForAccounts2023-05-012024-09-3010743197ns10:FullAccounts2023-05-012024-09-3010743197ns10:RegisteredOffice2023-05-012024-09-3010743197ns5:CurrentFinancialInstruments2024-09-3010743197ns5:CurrentFinancialInstruments2023-04-3010743197ns5:Non-currentFinancialInstruments2024-09-3010743197ns5:Non-currentFinancialInstruments2023-04-3010743197ns5:ShareCapital2024-09-3010743197ns5:ShareCapital2023-04-3010743197ns5:RetainedEarningsAccumulatedLosses2024-09-3010743197ns5:RetainedEarningsAccumulatedLosses2023-04-3010743197ns5:PlantMachinery2023-05-012024-09-3010743197ns5:PlantMachinery2023-04-3010743197ns5:PlantMachinery2024-09-3010743197ns5:PlantMachinery2023-04-3010743197ns5:CostValuation2023-04-3010743197ns5:AdditionsToInvestments2024-09-3010743197ns5:CostValuation2024-09-3010743197ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010743197ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3010743197ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-09-3010743197ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-04-30107431971ns10:Director12023-04-30107431971ns10:Director12022-04-30107431971ns10:Director12023-05-012024-09-30107431971ns10:Director12022-05-012023-04-30107431971ns10:Director12024-09-30107431971ns10:Director12023-04-30
REGISTERED NUMBER: 10743197 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 MAY 2023 TO 30 SEPTEMBER 2024

FOR

CHELSEA SURGICAL CONSULTING LTD

CHELSEA SURGICAL CONSULTING LTD (REGISTERED NUMBER: 10743197)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 MAY 2023 TO 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Certified Accountants' Report 7

CHELSEA SURGICAL CONSULTING LTD

COMPANY INFORMATION
FOR THE PERIOD 1 MAY 2023 TO 30 SEPTEMBER 2024







DIRECTOR: Mrs S C Grafin Von Roon





REGISTERED OFFICE: The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG





REGISTERED NUMBER: 10743197 (England and Wales)





ACCOUNTANTS: LFM
Chartered Certified Accountants
The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG

CHELSEA SURGICAL CONSULTING LTD (REGISTERED NUMBER: 10743197)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,402 2,288
Investments 5 237,869 113,456
239,271 115,744

CURRENT ASSETS
Debtors 6 217,395 161,545
Cash at bank 79,805 112,360
297,200 273,905
CREDITORS
Amounts falling due within one year 7 69,552 55,478
NET CURRENT ASSETS 227,648 218,427
TOTAL ASSETS LESS CURRENT
LIABILITIES

466,919

334,171

CREDITORS
Amounts falling due after more than one
year

8

-

(2,327

)

PROVISIONS FOR LIABILITIES (43,184 ) (23,576 )
NET ASSETS 423,735 308,268

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 423,734 308,267
SHAREHOLDERS' FUNDS 423,735 308,268

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHELSEA SURGICAL CONSULTING LTD (REGISTERED NUMBER: 10743197)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 March 2025 and were signed by:





Mrs S C Grafin Von Roon - Director


CHELSEA SURGICAL CONSULTING LTD (REGISTERED NUMBER: 10743197)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 MAY 2023 TO 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

Chelsea Surgical Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2023 - 1 ) .

CHELSEA SURGICAL CONSULTING LTD (REGISTERED NUMBER: 10743197)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 MAY 2023 TO 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2023 3,415
Additions 2,456
Disposals (1,118 )
At 30 September 2024 4,753
DEPRECIATION
At 1 May 2023 1,127
Charge for period 2,224
At 30 September 2024 3,351
NET BOOK VALUE
At 30 September 2024 1,402
At 30 April 2023 2,288

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 May 2023 113,456
Additions 124,413
At 30 September 2024 237,869
NET BOOK VALUE
At 30 September 2024 237,869
At 30 April 2023 113,456

6. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Trade debtors 29,222 23,903
Other debtors 171,756 102,503
200,978 126,406

Amounts falling due after more than one year:
Other debtors 16,417 35,139

Aggregate amounts 217,395 161,545

CHELSEA SURGICAL CONSULTING LTD (REGISTERED NUMBER: 10743197)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 MAY 2023 TO 30 SEPTEMBER 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors - 2,215
Taxation and social security 63,422 36,321
Other creditors 6,130 16,942
69,552 55,478

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Other creditors - 2,327

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 30 September 2024 and the year ended 30 April 2023:

2024 2023
£    £   
Mrs S C Grafin Von Roon
Balance outstanding at start of period 39,548 (79,627 )
Amounts advanced 179,386 120,139
Amounts repaid (177,557 ) (964 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period 41,377 39,548

The overdrawn directors loan account was repaid within 9 months of the financial year end.

Interest of £169 (2023: £135) was charged on the overdrawn balance and is included within other interest received.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mrs S C Grafin Von Roon.

CHARTERED CERTIFIED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
CHELSEA SURGICAL CONSULTING LTD

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Chelsea Surgical Consulting Ltd for the period ended 30 September 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the director of Chelsea Surgical Consulting Ltd in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Chelsea Surgical Consulting Ltd and state those matters that we have agreed to state to the director of Chelsea Surgical Consulting Ltd in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that Chelsea Surgical Consulting Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Chelsea Surgical Consulting Ltd. You consider that Chelsea Surgical Consulting Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Chelsea Surgical Consulting Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






LFM
Chartered Certified Accountants
The Stables
23b Lenten Street
Alton
Hampshire
GU34 1HG


31 March 2025